Your browser doesn't support javascript.
loading
Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.
Bellone, S; Tassi, R; Betti, M; English, D; Cocco, E; Gasparrini, S; Bortolomai, I; Black, J D; Todeschini, P; Romani, C; Ravaggi, A; Bignotti, E; Bandiera, E; Zanotti, L; Pecorelli, S; Ardighieri, L; Falchetti, M; Donzelli, C; Siegel, E R; Azodi, M; Silasi, D-A; Ratner, E; Schwartz, P E; Rutherford, T J; Santin, A D.
Affiliation
  • Bellone S; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8063, USA.
Br J Cancer ; 109(2): 462-71, 2013 Jul 23.
Article in En | MEDLINE | ID: mdl-23807163

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / Mammaglobin B / Antigens, Neoplasm Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / Mammaglobin B / Antigens, Neoplasm Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido